X-154310858-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_ModerateBP6_ModerateBS2
The NM_012253.4(TKTL1):āc.373A>Gā(p.Ser125Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0000132 in 1,209,183 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Genomes: š 0.000045 ( 0 hom., 2 hem., cov: 23)
Exomes š: 0.000010 ( 0 hom. 2 hem. )
Consequence
TKTL1
NM_012253.4 missense
NM_012253.4 missense
Scores
1
16
Clinical Significance
Conservation
PhyloP100: 6.64
Genes affected
TKTL1 (HGNC:11835): (transketolase like 1) The protein encoded by this gene is a transketolase that acts as a homodimer and catalyzes the conversion of sedoheptulose 7-phosphate and D-glyceraldehyde 3-phosphate to D-ribose 5-phosphate and D-xylulose 5-phosphate. This reaction links the pentose phosphate pathway with the glycolytic pathway. Variations in this gene may be the cause of Wernicke-Korsakoff syndrome. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.06949088).
BP6
Variant X-154310858-A-G is Benign according to our data. Variant chrX-154310858-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 2459762.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Hemizygotes in GnomAd4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TKTL1 | NM_012253.4 | c.373A>G | p.Ser125Gly | missense_variant | 4/13 | ENST00000369915.8 | NP_036385.3 | |
TKTL1 | NM_001145933.2 | c.355A>G | p.Ser119Gly | missense_variant | 4/13 | NP_001139405.1 | ||
TKTL1 | NM_001145934.2 | c.205A>G | p.Ser69Gly | missense_variant | 3/12 | NP_001139406.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TKTL1 | ENST00000369915.8 | c.373A>G | p.Ser125Gly | missense_variant | 4/13 | 1 | NM_012253.4 | ENSP00000358931 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000447 AC: 5AN: 111785Hom.: 0 Cov.: 23 AF XY: 0.0000589 AC XY: 2AN XY: 33959
GnomAD3 genomes
AF:
AC:
5
AN:
111785
Hom.:
Cov.:
23
AF XY:
AC XY:
2
AN XY:
33959
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000604 AC: 11AN: 181989Hom.: 0 AF XY: 0.0000150 AC XY: 1AN XY: 66559
GnomAD3 exomes
AF:
AC:
11
AN:
181989
Hom.:
AF XY:
AC XY:
1
AN XY:
66559
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000100 AC: 11AN: 1097398Hom.: 0 Cov.: 30 AF XY: 0.00000551 AC XY: 2AN XY: 362768
GnomAD4 exome
AF:
AC:
11
AN:
1097398
Hom.:
Cov.:
30
AF XY:
AC XY:
2
AN XY:
362768
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000447 AC: 5AN: 111785Hom.: 0 Cov.: 23 AF XY: 0.0000589 AC XY: 2AN XY: 33959
GnomAD4 genome
AF:
AC:
5
AN:
111785
Hom.:
Cov.:
23
AF XY:
AC XY:
2
AN XY:
33959
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
3
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 25, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T;.
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;.;.
MutationTaster
Benign
D;N;N
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N
REVEL
Uncertain
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
B;.;.
Vest4
MutPred
Gain of catalytic residue at S125 (P = 0.054);Gain of catalytic residue at S125 (P = 0.054);.;
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at